UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 32.

Glanzmann, C. Medication safety in children. 2015, University of Basel, Faculty of Science.

Oehler, C; Lang, S; Dimmerling, P; Bolesch, C; Klöck, S; Tini, A; Glanzmann, C; Najafi, Y; Studer, G; Zwahlen, D (2014). PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers. Radiation Oncology, 9:229.

Studer, G; Stocker, D N; Loewenich, K F; Glanzmann, C (2014). 40/42 Gy in 13 fractions: a safe dose for the brachial plexus. Journal of Nuclear Medicine & Radiation Therapy, 5(168 ):online.

Janssen, S; Glanzmann, C; Bauernfeind, P; Stieb, S; Studer, G; Brown, M; Riesterer, O (2014). Clinical experience of SIB-IMRT in anal cancer and selective literature review. Radiation Oncology, 9:199.

Bosset, J F; Calais, G; Mineur, L; Maingon, P; Stojanovic-Rundic, S; Bensadoun, R J; Bardet, E; Beny, A; Ollier, J C; Bolla, M; Marchal, P; Van Laethem, J L; Klein, V; Giralt, J; Clavère, P; Glanzmann, C; Cellier, P; Collette, L (2014). Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncology, 15(2):184-190.

Janssen, S; Glanzmann, C; Holzmann, D; Studer, G (2014). IMRT for nasal tumors - local control and cosmetic outcome. Journal of Nuclear Medicine & Radiation Therapy:5:170.

Janssen, S; Glanzmann, C; Huber, G; Studer, G (2014). Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary. Strahlentherapie und Onkologie, 190(4):386-393.

Holz-Sapra, E; Glanzmann, C; Schmid, S; Went, P; Studer, G (2014). Lymphoepithelial carcinoma of the salivary glands: case report of a rare cancer and review of the literature. Journal of Medical Research and Development, 3(4):184-192.

Studer, G; Glanzmann, C; Bredell, M (2013). Kurative Bestrahlung von Kopf-Hals-Tumoren - Toleranzgewinn gegenüber früheren Techniken. info@onkologie, (5):7-11.

Studer, G; Glanzmann, C; Rordorf, T (2013). Kurative Radiochemotherapie von Pharynx-Tumoren. Heutiger Stand offener Forschungsfragen. info@onkologie, (5):11-14.

Studer, G; Linsenmeier, C; Riesterer, O; Najafi, Y; Brown, M; Yousefi, B; Bredell, M; Huber, G; Schmid, S; Studer, S; Zwahlen, R; Rordorf, T; Glanzmann, C (2013). Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiation Oncology, 8:259.

Studer, G; Glanzmann, C (2013). Volumetric stratification of cT4 stage head and neck cancer. Strahlentherapie und Onkologie, 189(10):867-873.

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Ghadjar, P; Simcock, M; Studer, G; Allal, A; Ozsahin, M; Bernier, J; Töpfer, M; Zimmermann, F; Betz, M; Glanzmann, C; Aebersold, D (2012). Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). International Journal of Radiation Oncology, Biology and Physics, 82(2):524-531.

Peponi, E; Glanzmann, C; Willi, B; Huber, G; Studer, G (2011). Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiation Oncology, 6:1.

Studer, G; Brown, M; Salgueiro, E B; Schmückle, H; Romancuk, N; Winkler, G; Lee, S J; Sträuli, A; Kissling, B; Dummer, R; Glanzmann, C (2011). Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent Cetuximab and IMRT. International Journal of Radiation Oncology, Biology and Physics, 81(1):110-117.

Studer, G; Rordorf, T; Glanzmann, C (2011). Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer. Radiation Oncology, 6:120.

Studer, G; Glanzmann, C (2011). Increased recurrences using IMRT in the postoperative setting? American Journal of Clinical Oncology, 34(4):442.

Studer, G; Glanzmann, C; Studer, S P; Grätz, K W; Bredell, M; Locher, M C; Lütolf, U M; Zwahlen, R A (2011). Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT). Schweizer Monatsschrift für Zahnmedizin SMfZ, 121(3):216-229.

Studer, G; Peponi, E; Kloeck, S; Dossenbach, T; Huber, G; Glanzmann, C (2010). Surviving hypopharynx-larynx carcinoma in the era of IMRT. International Journal of Radiation Oncology, Biology and Physics, 77(5):1391-1396.

Peponi, E; Glanzmann, C; Kunz, G; Renner, C; Tomuschat, K; Studer, G (2010). Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) in nasopharyngeal cancer. Strahlentherapie und Onkologie:135-142.

Studer, G; Seifert, Burkhardt; Glanzmann, C (2008). Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pre-treatment staging? Strahlentherapie und Onkologie, 184(11):580-585.

Studer, G; Graetz, K W; Glanzmann, C (2008). Outcome in recurrent head neck cancer treated with salvage-IMRT. Radiation Oncology, 3:43:1-7.

Studer, G M; Glanzmann, C (2008). Patterns of Failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al. (Int J Radiat Oncol Biol Phys 2008;71:377-385). International Journal of Radiation Oncology, Biology and Physics, 72(4):1271-1272.

Studer, G; Glanzmann, C; Studer, S P; Grätz, K W; Lütolf, U M; Zwahlen, R A (2007). Empfehlung für die Zahnsanierung vor intensitätsmodulierter Radiotherapie (IMRT). UniversitätsSpital Zürich (USZ)-Richtlinien-Anpassung. Schweizer Monatsschrift für Zahnmedizin SMfZ, 117(6):637-647.

Oehler-Jänne, C; Seifert, Burkhardt; Lütolf, U M; Studer, G; Glanzmann, C; Ciernik, I F (2007). Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy, 6(3):218-226.

Studer, G; Zwahlen, R A; Grätz, K W; Davis, B J; Glanzmann, C (2007). IMRT in oral cavity cancer. Radiation Oncology, 2 : 16:1-7.

Studer, G; Huguenin, P U; Davis, J B; Kunz, G; Lütolf, U M; Glanzmann, C (2006). IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiation Oncology, 1:7.

Studer, G; Furrer, K; Davis, B J; Stoeckli, S S; Zwahlen, R A; Luetolf, U M; Glanzmann, C (2006). Postoperative IMRT in head and neck cancer. Radiation Oncology, 1 : 40:1-8.

Studer, G; Grätz, K W; Glanzmann, C (2004). Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlentherapie und Onkologie, 180(4):233-240.

Pruschy, M; Shi, Y Q; Crompton, N E; Steinbach, J P; Aguzzi, A; Glanzmann, C; Bodis, S (1997). The proto-oncogene c-fos mediates apoptosis in murine T-lymphocytes induced by ionizing radiation and dexamethasone. Biochemical and Biophysical Research Communications (BBRC), 241(2):519-524.

Glanzmann, C; Grätz, K W (1995). Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiotherapy and Oncology, 36(2):94-100.

This list was generated on Sun Jul 23 19:25:28 2017 CEST.